North America:
The North American proton pump inhibitors (PPIs) market is a leading segment within the global pharmaceutical industry, driven by high healthcare expenditure and advanced medical infrastructure. The demand for PPIs is supported by the high prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. Additionally, the region benefits...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian